Parasympathetic dysfunction in hypertrophic cardiomyopathy assessed by heart rate variability: Comparison between short-term and 24-h measurements

Clinical Physiology and Functional Imaging

Volumn 25, Issue 2, 2005, Pages 90-99

  Mörner, Stellan ^a   Wiklund, Urban ^a   Rask, Peter ^a,b   Olofsson, Bert Ove ^a   Kazzam, Elsadig ^a,c   Waldenström, Anders ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Autonomic nervous system; Cross sectional study; Heart rate variability; Hypertrophic cardiomyopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AMBULATORY MONITORING; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR AUTOREGULATION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONSENSUS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; FATALITY; FEMALE; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 14844361975     PISSN: 14750961     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2004.00595.x     Document Type: Article

References (39)

1. Ajiki K, Murakawa Y, Yanagisawa-Miwa A, Usui M, Yamashita T, Oikawa N, Inouc H. Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. Am J Cordiol (1993); 71: 1316-1320.
2. Aronson D, Burger AJ. Effect of beta-blockade on heart rate variability in decompensated heart failure. Int J Cordiol (2001); 79: 31-39.
3. Bonaduce D, Petretta M, Betocchi S, Ianniciello A, Marciano F, Apicella C, Losi MA, Boccalatte M, Chiariello M. Heart rate variability in patients with hypertrophic cardiomyopathy: association with clinical and echocardiographic features. Am Heart J (1997); 134(Pt 1): 165-172.
4. Bonnemeier H, Richardt G, Potratz J, Wiegand UK, Brandes A, Kluge N, Katus HA. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol (2003); 14 791-799.
5. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation (1997); 95: 1449-1454.
6. Brush JE, Jr., Eisenhofer G, Garty M, Stull R, Macon BJ, Cannon RO, III, Panza JA, Epstein SE, Goldstein DS. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation (1989); 79: 836-844.
7. Cook JR, Bigger JT, Jr, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol (1991); 17: 480-484.
8. Counihan PJ, Fei L, Bashir Y, Farrell TG, Haywood GA, McKenna WJ. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation (1993); 88(Pt 1): 1682-1690.
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichck N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986); 57: 450-458.
10. Doven O, Sayin T, Guldal M, Karaoguz R, Oral D. Heart rate variability in hypertrophic obstructive cardiomyopathy: association with functional classification and left ventricular outflow gradients. Int J Cardiol (2001); 77: 281-286.
11. Eckberg DL, Sleight P. Myocardial ischemia. In: Human Baroreflexes in Health and Disease (1992), pp. 347-366. Clarendon, Oxford.
12. Elliott PM, McKenna WJ. Hypertrophic cardiomyopathy. In: Cardiology (eds Crawford, MH, DiMarco, JP) (2001), pp. 12.1-12.12. Mosby International Ltd, London.
13. Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol (1997); 30: 1009-1014.
14. Fei L, Slade AK, Prasad K, Malik M, McKenna WJ, Camm AJ. Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy? J Am Coll Cardiol (1995); 26: 472-480.
15. Fei L, Copie X, Malik M, Camm AJ. Short- and long-term assessment of heart rate variability for risk stratification after acute myocardial infarction. Am J Cardiol (1996); 77: 681-684.
16. Grassi G, Giannattasio C, Seravalle G, Cattaneo BM, Cleroux J, Mancia G. Cardiogenic reflexes and left ventricular hypertrophy. Eur Heart J (1990); 11(Suppl. G): 95-99.
17. Gupta BN, Thames MD. Behavior of left ventricular mechanoreceptors with myelinated and nonmyelinated afferent vagal fibers in cats. Circ Res (1983); 52: 291-301.
18. Guzzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J (1995); 16: 1100-1107.
19. Hainsworth R. Reflexes from the heart. Physiol Rev (1991); 71: 617-658.
20. Keeley EC, Page RL, Lange RA, Willard JE, Landau C, Hillis I.D. Influence of metoprolol on heart rate variability in survivors of remote myocardial infarction. Am J Cardiol (1996); 77: 557-560.
21. Kleiger RE, Miller JP, Bigger JT, Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987); 59: 256-262.
22. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation (2003); 107: 565-570.
23. Lefroy DC, de Silva R, Choudhury L, Uren NG, Crake T, Rhodes CG, Lammertsma AA, Boyd H, Patsalos PN, Nihoyannopoulos P. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol (1993); 22: 1653-1660.
24. Limbruno U, Strata G, Zucchi R, Baglini R, Mengozzi G, Balbarini A, Mariani M. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy. Eur Heart J (1998); 19: 146-153.
25. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med (1976); 294: 1165-1170.
26. Malik M, Bigger TJ, Camm JA, Kleiger RE, Malliano A, Moss AJ, Schwartz PJ. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J (1996); 17: 354-381.
27. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA (2002); 287: 1308-1320.
28. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults (see comments). Circulation (1995); 92: 785-789.
29. Pumprla J, Howorka K, Groves D, Chester M, Nolan J. Functional assessment of heart rate variability: physiological basis and practical applications. Int J Cardiol (2002); 84: 1-14.
30. Rangno RE, Langlois S, Lutterodt A. Metoprolol withdrawal phenomena: mechanism and prevention. Clin Pharmacol Ther (1982); 31: 8-15.
31. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996); 93: 841-842.
32. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978); 58: 1072-1083.
33. Sandrone G, Mortara A, Torzillo D, La Rovere MT, Malliani A, Lombardi F. Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol (1994); 74: 340-345.
34. Schafers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res (1998); 82 57-62.
35. Sleight P, Widdicombe JG. Action potentials in afferent fibres from pericardial mechanoreceptors in the dog. J Physiol (1965); 181: 259-269.
36. Tanabe T, Iwamoto T, Fusegawa Y, Yoshioka K, Shima Y. Alterations of sympathovagal balance in patients with hypertrophic and dilated cardiomyopathies assessed by spectral analysis of RR interval variability. Eur Heart J (1995); 16: 799-807.
37. Towbin J, Roberts R. Cardiovascular diseases due to genetic abnormalities. In: Hurst's The Heart: Arteries and Veins, 8th edn (eds Schlant, RC, Alexander, RW) (1994), pp. 1725-1759. McGraw-Hill Inc., New York.
38. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation (1990); 82: 1095-1105.
39. Zipes DP, Jalife J. Cardiac Electrophysiology: from Cell to Bedside (1990). WB Saunders, Philadelphia, USA.